Search research articles
Contact Us
Filters
Showing results (101-110 of 150) with videos related to
Page
of 15
Sort By:
British Journal of Cancer
|
October 14, 2005
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease
A Berruti, M Tucci, A Mosca, et al.
Oncology
|
December 2, 2005
Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes
M Donadio, M Ardine, A Berruti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2002
Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma
E Bollito, A Berruti, M Bellina, et al.
Breast Cancer Research and Treatment
|
January 5, 2002
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease
C Fiorentino, A Berruti, A Bottini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2000
Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines
A Berruti, P Sperone, A Bottini, et al.
Tumori
|
June 10, 1998
Randomized comparison of goserelin acetate versus mitomycin C plus goserelin acetate in previously untreated prostate cancer patients with bone metastases
D Fontana, O Bertetto, G Fasolis, et al.
Sexually Transmitted Diseases
|
May 2, 2020
Population-level Benefits of Extragenital Gonorrhea Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis
Rebecca Earnest, Minttu M Rönn, Meghan Bellerose, et al.
Anticancer Research
|
March 12, 1998
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P)
A Berruti, S Cerutti, G Fasolis, et al.
Cancer Chemotherapy and Pharmacology
|
June 8, 2001
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial
M Donadio, E Manzin, A Berruti, et al.
British Journal of Cancer
|
November 17, 2001
Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer
A Bottini, A Berruti, A Bersiga, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 150) with videos related to
Sort By:
Page
of 15
British Journal of Cancer
|
October 14, 2005
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease
A Berruti, M Tucci, A Mosca, et al.
Oncology
|
December 2, 2005
Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes
M Donadio, M Ardine, A Berruti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2002
Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma
E Bollito, A Berruti, M Bellina, et al.
Breast Cancer Research and Treatment
|
January 5, 2002
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease
C Fiorentino, A Berruti, A Bottini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2000
Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines
A Berruti, P Sperone, A Bottini, et al.
Tumori
|
June 10, 1998
Randomized comparison of goserelin acetate versus mitomycin C plus goserelin acetate in previously untreated prostate cancer patients with bone metastases
D Fontana, O Bertetto, G Fasolis, et al.
Sexually Transmitted Diseases
|
May 2, 2020
Population-level Benefits of Extragenital Gonorrhea Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis
Rebecca Earnest, Minttu M Rönn, Meghan Bellerose, et al.
Anticancer Research
|
March 12, 1998
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P)
A Berruti, S Cerutti, G Fasolis, et al.
Cancer Chemotherapy and Pharmacology
|
June 8, 2001
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial
M Donadio, E Manzin, A Berruti, et al.
British Journal of Cancer
|
November 17, 2001
Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer
A Bottini, A Berruti, A Bersiga, et al.
Page
of 15